Comparison of the Therapeutic Effects of Balloon Assisted Enteroscopy Assisted Narrow Incision and Balloon Dilation in the Treatment of Crohn's Disease Small Intestinal Stenosis
CD stenosis
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
This study is designed as a controlled trial to evaluate the efficacy of balloon-assisted enteroscopy-guided radial incision therapy for the treatment of stricturing small bowel Crohn's disease. The study aims to compare therapeutic outcomes, procedure-related complications, and recurrence rates in patients with stricturing small bowel Crohn's disease undergoing balloon-assisted enteroscopy-guided radial incision therapy. The results are expected to provide a novel and reliable treatment option for patients with stricturing Crohn's disease and to lay a foundation for improving disease-related symptoms and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
February 13, 2026
December 1, 2025
1.8 years
February 9, 2026
February 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients not requiring additional therapeutic interventions at 1-year follow-up
Percentage of patients who do not require any new therapeutic intervention, including endoscopic balloon dilation (EBD), endoscopic stricture incision (EST), or surgery, within 1 year after the initial procedure.
1 year
Secondary Outcomes (6)
Proportion of patients not requiring additional therapeutic interventions at 3-year follow-up
3 years
Proportion of patients not requiring additional therapeutic interventions at 5-year follow-up
5 years
Safety assessment of the two treatment methods
Within 2 months post-procedure
Immediate technical success of the procedure
At the time of procedure
Symptom-free duration within 1 year post-procedure
1 year
- +1 more secondary outcomes
Study Arms (3)
No Intervention
SHAM COMPARATORPatients in this arm will not receive endoscopic interventional treatment for small bowel strictures and will be managed with standard medical therapy and clinical observation.
Balloon-assisted enteroscopy-guided balloon dilation
EXPERIMENTALPatients in this arm will undergo balloon dilation of small bowel strictures under balloon-assisted enteroscopy to relieve luminal narrowing.
Balloon-assisted enteroscopy-guided stricture incision
EXPERIMENTALPatients in this arm will receive balloon-assisted enteroscopy-guided radial incision of small bowel strictures under direct endoscopic visualization.
Interventions
Balloon-assisted enteroscopy-guided stricture incision versus balloon dilation
Balloon-assisted enteroscopy-guided balloon dilation
Eligibility Criteria
You may qualify if:
- Age between 16 and 75 years.
- Diagnosis of Crohn's disease with primary or secondary small bowel stricture confirmed by imaging studies, or small bowel stricture identified by enteroscopy.
- Inadequate response to conventional medical therapy and step-up treatment strategies.
- Stricture length less than 5 cm.
- Signed informed consent form.
You may not qualify if:
- Bowel wall thickening with Limberg grade IV blood flow on intestinal ultrasound, or presence of complications such as perforation, fistula, deep ulcer, inflammatory mass, or abscess.
- Deep ulcer in the stricture segment observed by enteroscopy, potentially involving the muscular layer.
- Presence of strictures in the esophagus, stomach, or duodenum.
- Presence of colorectal stricture or ileocecal valve stricture.
- Small bowel stricture complicated by abscess, fistula, or severe angulation.
- Patients with ≥3 small bowel strictures or stricture length ≥5 cm.
- Strictures previously treated with stent placement, dilation, or incision but without sustained symptom-free remission for at least 1 year.
- Pregnancy or breastfeeding.
- Inability to undergo endoscopic treatment.
- Severe coagulation disorders (platelet count \<70,000/μL, INR \>1.5).
- Concomitant advanced tumors or other severe organ diseases.
- Suspected localized intestinal malignancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yan Chen, PhD
Second Affiliated Hospital of Zhejiang University School of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2026
First Posted
February 13, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
February 13, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share